Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers

[1]  J S Fowler,et al.  Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. , 1994, The American journal of psychiatry.

[2]  D. King,et al.  The Effect of Neuroleptics on Cognitive and Psychomotor Function , 1992, British Journal of Psychiatry.

[3]  M. Martres,et al.  Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. , 1992, European journal of pharmacology.

[4]  K. Spaendonck,et al.  Haloperidol and cognitive shifting , 1989, Neuropsychologia.

[5]  J. Hedreen,et al.  Sigma receptors in post-mortem human brains. , 1988, The Journal of pharmacology and experimental therapeutics.

[6]  J. Saint-Cyr,et al.  Procedural learning and neostriatal dysfunction in man. , 1988, Brain : a journal of neurology.

[7]  U. Saarialho-Kere,et al.  Psychomotor, respiratory and neuroendocrinological effects of nalbuphine and haloperidol, alone and in combination, in healthy subjects. , 1988, British journal of clinical pharmacology.

[8]  D. Salmon,et al.  Impaired learning of a motor skill in patients with Huntington's disease. , 1988, Behavioral neuroscience.

[9]  M. Horstink,et al.  Cognitive and motor shifting aptitude disorder in Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[10]  B. Saletu,et al.  Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies: Part II. , 1983, International journal of clinical pharmacology, therapy, and toxicology.

[11]  T. Shallice.  Specific impairments of planning. , 1982, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[12]  A. Cools.  Role of the neostriatal dopaminergic activity in sequencing and selecting behavioural strategies: Facilitation of processes involved in selecting the best strategy in a stressful situation , 1980, Behavioural Brain Research.

[13]  R. Ohman,et al.  Pharmacokinetic studies on haloperidol in man. , 1976, Current therapeutic research, clinical and experimental.

[14]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .

[15]  N. James,et al.  Low dosage haloperidol and induced anxiety in normal volunteers. , 1973, The New Zealand medical journal.

[16]  W. Janke,et al.  Double-blind Psychometric Evaluation of Pimozide and Haloperidol versus Placebo in Emotionally labile Volunteers under two Different Work Load Conditions , 1972 .

[17]  C. Kornetsky,et al.  Relationships between effects of a number of centrally acting drugs and personality. , 1957, A.M.A. archives of neurology and psychiatry.

[18]  S. Bischoff.  LIMBIC SELECTIVE NEUROLEPTICS , 1992, Clinical neuropharmacology.

[19]  P. Boyer,et al.  Etude multicentrique contrôlée en double insu: amisulpride (Solian®200) versus halopéridol à forte dose dans les états psychotiques aigus , 1988 .

[20]  L. Squire,et al.  Effects of psychotropic drugs on cognition and memory in normal humans and animals , 1987 .

[21]  A. Puech,et al.  Determinants for clinical activity of neuroleptic drugs: chemical substances, doses, assessment tools , 1987 .

[22]  H. Meltzer,et al.  Psychopharmacology : the third generation of progress , 1987 .

[23]  J. Larsen,et al.  Receptor-binding profiles of neuroleptics. , 1985, Psychopharmacology. Supplementum.

[24]  B. Saletu,et al.  Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I. , 1983, International journal of clinical pharmacology, therapy, and toxicology.

[25]  C. Kornetsky,et al.  A comparison of the psychological effects of acute and chronic administration of chlorpromazine and secobarbital (quinalbarbitone) in schizophrenic patients. , 1959, The Journal of mental science.

[26]  D. Wechsler.  A Standardized Memory Scale for Clinical Use , 1945 .